Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 11 01:04PM ET
83.43
Dollar change
-0.45
Percentage change
-0.53
%
IndexRUT P/E34.65 EPS (ttm)2.41 Insider Own1.09% Shs Outstand50.38M Perf Week-0.09%
Market Cap4.19B Forward P/E15.69 EPS next Y5.32 Insider Trans-1.18% Shs Float49.68M Perf Month-8.71%
Income123.81M PEG2.16 EPS next Q1.17 Inst Own112.18% Short Float9.19% Perf Quarter13.89%
Sales1.36B P/S3.08 EPS this Y15.96% Inst Trans-0.02% Short Ratio7.50 Perf Half Y-2.90%
Book/sh17.44 P/B4.78 EPS next Y15.80% ROA5.46% Short Interest4.57M Perf Year-2.00%
Cash/sh5.96 P/C14.00 EPS next 5Y16.05% ROE13.97% 52W Range70.25 - 97.97 Perf YTD-2.43%
Dividend Est.1.00 (1.20%) P/FCF110.62 EPS past 5Y17.09% ROI5.90% 52W High-14.84% Beta0.39
Dividend TTM- Quick Ratio2.09 Sales past 5Y6.80% Gross Margin51.08% 52W Low18.77% ATR (14)2.49
Dividend Ex-Date- Current Ratio3.49 EPS Y/Y TTM-4.08% Oper. Margin15.13% RSI (14)49.15 Volatility3.15% 2.91%
Employees3657 Debt/Eq1.39 Sales Y/Y TTM9.84% Profit Margin9.10% Recom1.45 Target Price110.80
Option/ShortYes / Yes LT Debt/Eq1.39 EPS Q/Q36.24% Payout0.00% Rel Volume0.47 Prev Close83.88
Sales Surprise0.86% EPS Surprise4.36% Sales Q/Q8.59% EarningsNov 07 BMO Avg Volume609.26K Price83.43
SMA20-3.06% SMA503.34% SMA2000.86% Trades Volume164,407 Change-0.53%
Date Action Analyst Rating Change Price Target Change
Dec-06-24Initiated JP Morgan Overweight $116
Nov-08-24Upgrade Raymond James Outperform → Strong Buy $120
Sep-13-24Initiated CL King Buy $116
Sep-11-24Initiated BofA Securities Neutral $85
Sep-10-24Initiated BTIG Research Buy $112
Jun-12-24Upgrade Needham Hold → Buy $112
Oct-13-22Initiated Mizuho Buy $90
Jan-27-22Downgrade Needham Buy → Hold
Dec-15-21Downgrade Citigroup Buy → Neutral $75 → $59
Aug-17-21Resumed Raymond James Outperform $75
Dec-06-24 09:40AM
Dec-04-24 09:55AM
06:22AM
Dec-03-24 01:16AM
Nov-14-24 05:35AM
04:12PM Loading…
Nov-12-24 04:12PM
09:40AM
Nov-11-24 09:55AM
Nov-07-24 09:30AM
07:25AM
06:26AM
06:00AM
Nov-06-24 09:15AM
07:09AM
Oct-31-24 10:01AM
05:28PM Loading…
Oct-09-24 05:28PM
Oct-03-24 04:05PM
Sep-24-24 08:00AM
Sep-20-24 12:54AM
Sep-02-24 09:35AM
Aug-23-24 09:22AM
Aug-16-24 09:08AM
06:33AM
Aug-15-24 06:30AM
Aug-12-24 07:47AM
Aug-09-24 09:40AM
09:35AM
Aug-08-24 07:25AM
06:25AM
06:00AM
09:55AM Loading…
Aug-07-24 09:55AM
09:40AM
Aug-01-24 07:00AM
Jul-30-24 06:00AM
Jul-29-24 10:20AM
Jul-16-24 09:45AM
Jul-12-24 11:38AM
Jul-10-24 09:55AM
Jul-08-24 04:05PM
Jun-27-24 09:35AM
Jun-19-24 01:26PM
04:52AM
Jun-18-24 04:15PM
Jun-14-24 09:40AM
Jun-13-24 10:19AM
Jun-03-24 09:45AM
May-30-24 02:41AM
02:41AM
May-29-24 09:40AM
May-27-24 12:45PM
May-24-24 09:55AM
May-23-24 12:00PM
06:00AM
May-22-24 09:13AM
02:06AM
May-21-24 04:05PM
May-17-24 12:00PM
10:20AM
May-14-24 09:15AM
May-13-24 09:40AM
May-10-24 03:57PM
12:41PM
10:53AM
10:37AM
May-09-24 10:55AM
09:30AM
07:20AM
06:39AM
06:28AM
06:00AM
May-08-24 09:15PM
May-06-24 09:16AM
May-01-24 11:51AM
Apr-12-24 09:03AM
Apr-10-24 04:58PM
Apr-08-24 03:20PM
Apr-05-24 09:48AM
Apr-04-24 06:30AM
Apr-01-24 08:00AM
Mar-29-24 09:30AM
Mar-11-24 09:30AM
Mar-06-24 06:54AM
Mar-05-24 06:18AM
06:00AM
Feb-27-24 12:00PM
Feb-21-24 05:57PM
05:55PM
Feb-18-24 01:26PM
Feb-09-24 10:39AM
10:34AM
09:40AM
Feb-08-24 10:00PM
09:30AM
07:10AM
06:33AM
06:10AM
06:00AM
Feb-05-24 09:16AM
Feb-01-24 10:00AM
Jan-31-24 12:45PM
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lingamneni AnilaFormer OfficerNov 11 '24Proposed Sale90.686,238565,692Nov 12 11:26 AM
Strong Stewart WPresident, Global HospitalJul 26 '24Sale91.154,312393,03918,196Jul 29 05:03 PM
Strong Stewart WOfficerJul 26 '24Proposed Sale91.154,312393,039Jul 26 09:47 AM
Lingamneni AnilaEVP, Chief Technology OfficerJul 11 '24Sale90.002,136192,24021,410Jul 15 04:27 PM
Lingamneni AnilaEVP, Chief Technology OfficerJul 12 '24Sale90.00797,11021,331Jul 15 04:27 PM
Simon, ChristopherPresident & CEOJun 06 '24Option Exercise41.64104,5164,352,046433,877Jun 07 04:15 PM
Basil Michelle LEVP and General CounselMay 29 '24Sale88.0812,9901,144,20831,257May 29 05:38 PM
Strong Stewart WPresident, Global HospitalMay 29 '24Sale87.538,857775,25318,196May 29 05:27 PM
Strong Stewart WPresident, Global HospitalMay 20 '24Option Exercise56.572,241126,77320,437May 21 06:01 PM
Strong Stewart WPresident, Global HospitalMay 20 '24Sale95.1168665,24518,196May 21 06:01 PM
Llorens JosepEVP, Global ManufacturingMay 20 '24Sale95.0898793,84421,310May 21 05:52 PM
Llorens JosepEVP, Global ManufacturingMay 17 '24Sale94.8282277,94216,350May 21 05:52 PM
Basil Michelle LEVP and General CounselMay 20 '24Sale95.081,604152,50831,257May 21 05:46 PM
Basil Michelle LEVP and General CounselMay 17 '24Sale95.001,073101,93529,352May 21 05:46 PM
Strong Stewart WPresident, Global HospitalMay 16 '24Option Exercise57.602,410138,81618,018May 17 05:11 PM
Strong Stewart WPresident, Global HospitalMay 16 '24Sale96.0473370,39715,608May 17 05:11 PM
Basil Michelle LEVP and General CounselMay 16 '24Sale96.1498594,69830,425May 17 05:02 PM
Llorens JosepEVP, Global ManufacturingMay 16 '24Sale96.1477074,02817,172May 17 04:55 PM
Lingamneni AnilaEVP, Chief Technology OfficerMay 06 '24Sale95.002,305218,97512,295May 08 04:21 PM